TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03909750

Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD)

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“Withdrawn \[COVID restrictions prevent patient enrollment or treatment. Clinical Trial facility is being closed due to viral limitations and loss of staff to perform\]”

The sponsor’s own words in the registry.

Life of this trial

20192020202120222023202420252026Registered2019-04-08Started2019-04-10Suspended (as of)2024-10-01Primary completion2025-09-30

Vital statistics

Status
Suspended
Phase
Phase 1
Sponsor
Healeon Medical Inc
Sponsor type
Industry
Conditions
COPD; Respiratory Insufficiency
Interventions
Lipoaspiration; AD-cSVF; Normal Saline IV
Participants
50 (planned, not actual)
Sites
2
Countries
Honduras, United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.